Literature DB >> 2171598

Characterization of a macrophage-tropic HIV strain that does not alter macrophage cytokine production yet protects macrophages from superinfection by vesicular stomatitis virus.

R S Kornbluth1, J R Munis, P S Oh, P R Meylan, D D Richman.   

Abstract

Macrophages, unlike CD4+ T cells, can be productively infected by human immunodeficiency virus (HIV) without prior cellular activation. Cytopathic infection ensues without the induction of tumor necrosis factor alpha (TNF alpha), interleukin 1 beta (IL-1 beta), interleukin 6 (IL-6), or tissue factor genes. In detailed studies on TNF alpha, HIV infection did not affect the regulation of TNF alpha in response to bacterial lipopolysaccharide. In an effort to examine the interferon responsiveness of HIV-infected macrophages, the cells were challenged with vesicular stomatitis virus (VSV) with or without interferon pretreatment. Surprisingly, HIV-infected macrophages were completely resistant to VSV-induced lysis even in the absence of interferon; however, no interferon was detected in the supernatants of these infected cells. The resistance of HIV-infected macrophages to superinfection with VSV indicates a previously undescribed effect of HIV upon macrophage cellular metabolism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171598     DOI: 10.1089/aid.1990.6.1023

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  4 in total

Review 1.  Understanding and altering cell tropism of vesicular stomatitis virus.

Authors:  Eric Hastie; Marcela Cataldi; Ian Marriott; Valery Z Grdzelishvili
Journal:  Virus Res       Date:  2013-06-22       Impact factor: 3.303

2.  Induction of beta interferon by human immunodeficiency virus type 1 and its gp120 protein in human monocytes-macrophages: role of beta interferon in restriction of virus replication.

Authors:  S Gessani; P Puddu; B Varano; P Borghi; L Conti; L Fantuzzi; F Belardelli
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

3.  Prospective assessment of incidence of fulminant hepatitis in post-transfusion hepatitis: a study of 504 cases.

Authors:  S Takano; M Omata; M Ohto; Y Satomura
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

4.  Low autocrine interferon beta production as a gene therapy approach for AIDS: Infusion of interferon beta-engineered lymphocytes in macaques chronically infected with SIVmac251.

Authors:  Wilfried Gay; Evelyne Lauret; Bertrand Boson; Jérome Larghero; Franck Matheux; Sophie Peyramaure; Véronique Rousseau; Dominique Dormont; Edward De Maeyer; Roger Le Grand
Journal:  Retrovirology       Date:  2004-09-25       Impact factor: 4.602

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.